Monday, March 30, 2015
Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion
TEL AVIV (Reuters) - Israel's Teva Pharmaceutical Industries said it would buy U.S. neurology drug company Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of treatments for the central nervous system.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment